41O Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Outlook Therapeutics Inc

Watchlist Manager

Watchlist

Price: 0.861 EUR 14.8% Market Closed

Market Cap: €38.2m

	Outlook Therapeutics Inc F:41O	US
	Universal Display Corp NASDAQ:OLED	US
T	Takeda Pharmaceutical Co Ltd XMUN:TKD	JP
S	Siam Wellness Group PCL SET:SPA	TH
E	Endo International PLC F:EO7	IE
	PTT Oil and Retail Business PCL SET:OR	TH
	Pharmagest Interactive SA F:PHF	FR
	Tokyo Metro Co Ltd F:XO7	JP
R	Realtech AG XMUN:RTC	DE
M	Minor International PCL SET:MINT	TH

Profitability Summary

Outlook Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Negative Gross Margin

-46%

Negative 3Y Average Gross Margin

-7%

Negative Operating Margin

-14 256%

Negative 3Y Average Operating Margin

-10 909%

Negative Net Margin

-14 346%

Negative 3Y Average Net Margin

-14 056%

Negative Free Cash Flow Margin

-11 072%

Negative 3Y Average Free Cash Flow Margin

-9 308%

Exceptional ROE

198%

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-2 156%

Declining ROIC

-693% > -2 843%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.